Next generation patient-derived prostate cancer xenograft models
- PMID: 24589467
- PMCID: PMC4023366
- DOI: 10.4103/1008-682X.125394
Next generation patient-derived prostate cancer xenograft models
Abstract
There is a critical need for more effective therapeutic approaches for prostate cancer. Research in this area, however, has been seriously hampered by a lack of clinically relevant, experimental in vivo models of the disease. This review particularly focuses on the development of prostate cancer xenograft models based on subrenal capsule grafting of patients’ tumor tissue into nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice. This technique allows successful development of transplantable, patient-derived cancer tissue xenograft lines not only from aggressive metastatic, but also from localized prostate cancer tissues. The xenografts have been found to retain key biological properties of the original malignancies, including histopathological and molecular characteristics, tumor heterogeneity, response to androgen ablation and metastatic ability. As such, they are highly clinically relevant and provide valuable tools for studies of prostate cancer progression at cellular and molecular levels, drug screening for personalized cancer therapy and preclinical drug efficacy testing; especially when a panel of models is used to cover a broader spectrum of the disease. These xenograft models could therefore be viewed as next-generation models of prostate cancer.
Figures

Comment on
-
Development and characterization of efficient xenograft models for benign and malignant human prostate tissue.Prostate. 2005 Jul 1;64(2):149-59. doi: 10.1002/pros.20225. Prostate. 2005. PMID: 15678503
Similar articles
-
Development and characterization of efficient xenograft models for benign and malignant human prostate tissue.Prostate. 2005 Jul 1;64(2):149-59. doi: 10.1002/pros.20225. Prostate. 2005. PMID: 15678503
-
Transplantation of human prostate neoplasia into the nude mouse.Natl Cancer Inst Monogr. 1978 Dec;(49):67-9. Natl Cancer Inst Monogr. 1978. PMID: 86170
-
The growth and viability of human prostatic tissue maintained in immunosuppressed mice.Clin Oncol. 1978 Dec;4(4):347-51. Clin Oncol. 1978. PMID: 83214 No abstract available.
-
Pathology of prostate cancer.Cancer Metastasis Rev. 2002;21(3-4):381-95. doi: 10.1023/a:1021242813374. Cancer Metastasis Rev. 2002. PMID: 12549773 Review. No abstract available.
-
Applications of immunohistochemistry to the diagnosis and prognostication of prostate carcinoma and prostatic intraepithelial neoplasia.Pathol Annu. 1994;29 Pt 1:303-20. Pathol Annu. 1994. PMID: 7510385 Review. No abstract available.
Cited by
-
Animal models of bone metastatic prostate cancer.Investig Clin Urol. 2023 May;64(3):219-228. doi: 10.4111/icu.20230026. Investig Clin Urol. 2023. PMID: 37341002 Free PMC article. Review.
-
Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy.PLoS One. 2015 Dec 22;10(12):e0145176. doi: 10.1371/journal.pone.0145176. eCollection 2015. PLoS One. 2015. PMID: 26695660 Free PMC article.
-
The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype.PeerJ. 2021 Feb 1;9:e10280. doi: 10.7717/peerj.10280. eCollection 2021. PeerJ. 2021. PMID: 33585078 Free PMC article.
-
Precision or Personalized Medicine for Cancer Chemotherapy: Is there a Role for Herbal Medicine.Molecules. 2016 Jul 7;21(7):889. doi: 10.3390/molecules21070889. Molecules. 2016. PMID: 27399658 Free PMC article. Review.
-
The future of patient-derived xenografts in prostate cancer research.Nat Rev Urol. 2023 Jun;20(6):371-384. doi: 10.1038/s41585-022-00706-x. Epub 2023 Jan 17. Nat Rev Urol. 2023. PMID: 36650259 Free PMC article. Review.
References
-
- Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300. - PubMed
-
- Arora R, Koch MO, Eble JN, Ulbright TM, Li L, et al. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer. 2004;100:2362–6. - PubMed
-
- Bostwick DG, Shan A, Qian J, Darson M, Maihle NJ, et al. Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma. Cancer. 1998;83:1995–2002. - PubMed
-
- Ruijter ET, van de Kaa CA, Schalken JA, Debruyne FM, Ruiter DJ. Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications. J Pathol. 1996;180:295–9. - PubMed
-
- Wise AM, Stamey TA, McNeal JE, Clayton JL. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology. 2002;60:264–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials